PremiumThe FlyThird Point buys Capital One, cuts Microsoft in Q4 CVS Health price target raised to $74 from $58 at RBC Capital CVS Health price target raised to $70 from $66 at Deutsche Bank PremiumRatingsOptimistic Future for CVS Health: Strong Q4 2024 Performance and Promising 2025 Outlook CVS Health price target raised to $73 from $68 at Wells Fargo Positive Outlook and Attractive Valuation Drive Buy Rating for CVS Health PremiumThe FlyCVS Health upgraded to Outperform from Market Perform at Leerink CVS Health upgraded to Overweight at Cantor on increased confidence after Q4 CVS Health upgraded to Overweight from Neutral at Cantor Fitzgerald